Commodore Capital LP Merus N.V. Transaction History
Commodore Capital LP
- $1.18 Billion
- Q3 2024
A detailed history of Commodore Capital LP transactions in Merus N.V. stock. As of the latest transaction made, Commodore Capital LP holds 3,350,000 shares of MRUS stock, worth $140 Million. This represents 14.22% of its overall portfolio holdings.
Number of Shares
3,350,000
Previous 3,200,000
4.69%
Holding current value
$140 Million
Previous $189 Million
11.61%
% of portfolio
14.22%
Previous 16.98%
Shares
12 transactions
Others Institutions Holding MRUS
# of Institutions
200Shares Held
61.9MCall Options Held
243KPut Options Held
300K-
Rtw Investments, LP New York, NY4.17MShares$174 Million3.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$143 Million3.17% of portfolio
-
Wellington Management Group LLP Boston, MA2.89MShares$121 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$109 Million2.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.45MShares$103 Million4.42% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.92B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...